A pilot open-label phase II trial of rituximab for non-criteria manifestations of antiphospholipid syndrome
Author:
Publisher
Wiley
Subject
Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/art.37759/fullpdf
Reference35 articles.
1. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS);Miyakis;J Thromb Haemost,2006
2. Non-criteria manifestations of antiphospholipid syndrome;Erkan;Lupus,2010
3. The antiphospholipid syndrome as a model for B-cell-induced autoimmune diseases;Youinou;Thromb Res,2004
4. B-cell directed therapies in antiphospholipid antibody syndrome-new directions based on murine and human data;Khattri;Autoimmun Rev,2012
5. Prevention of murine antiphospholipid syndrome by BAFF blockade;Kahn;Arthritis Rheum,2008
Cited by 240 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Clinical aspects of antiphospholipid syndrome;Dubois' Lupus Erythematosus and Related Syndromes;2025
2. Case Report: Localized retinal ischemia revealing an antiphospholipids syndrome: A case report and review of the literature;F1000Research;2024-08-08
3. Dilemmas in the diagnosis and management of antiphospholipid syndrome;Journal of Thrombosis and Haemostasis;2024-08
4. Antiphospholipid syndrome in children;Best Practice & Research Clinical Rheumatology;2024-08
5. Successful treatment with rituximab in anti‐phospholipid syndrome nephropathy associated with systemic lupus erythematosus: A case report and literature review;Nephrology;2024-07-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3